Who
Jon Skinner
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Pulse Biosciences.
In numbers
- Trades disclosed
- 2
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Feb 2025
- Last trade
- 3 Feb 2025
- Last filed
- 28 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Feb 2025filed 28 Aug 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 3 Feb 2025filed 28 Aug 2026 | PLSE Pulse Biosciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.